Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls

References

• Hornnes P J. On the decrease of glucose tolerance in pregnancy. A review. Diabetes Metab 1985; 11: 310–315
   Google Scholar
• Ryan E A, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988; 67: 341–347
   PubMed Web of Science ®Google Scholar
• Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes 1991; 40: 18–24
   Google Scholar
• King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 1998; 21: B9–B13
   Web of Science ®Google Scholar
• Jawerbaum A, Gonzalez E. Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Curr Med Chem 2006; 13: 2127–2138
   Google Scholar
• Lepercq J. [Principal complications of pregnancy. Part one: gestational diabetes]. Rev Prat 2006; 56: 891–894
   Google Scholar
• Khatun N, Latif S A, Uddin M M. Pregnancy associated complications of mothers with gestational diabetes mellitus. Mymensingh Med J 2005; 14: 196–198
   Google Scholar
• Wroblewska-Seniuk K, Wender-Ozegowska E, Szczapa J, Chojnacka K, Bieganska E, Pietryga M, Biczysko R, Gadzinowski J. [Perinatal complications in newborns of mothers with gestational diabetes]. Med Wieku Rozwoj 2004; 8: 719–732
   Google Scholar
• Palik E, Baranyi E, Melczer Z, Audikovszky M, Szocs A, Winkler G, Cseh K. Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 2007; 76: 351–357
   PubMed Web of Science ®Google Scholar
• Pittas A G, Joseph N A, Greenberg A S. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004; 89: 447–452
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Hanley A J, Raif N, Connelly P W, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004; 27: 799–800
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Zinman B, Connelly P W, Sermer M, Hanley A J. Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test. Diabetes Care 2006; 29: 57–62
   PubMedGoogle Scholar
• Hu E, Liang P, Spiegelman B M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697–10703
   PubMed Web of Science ®Google Scholar
• Statnick M A, Beavers L S, Conner L J, Corominola H, Johnson D, Hammond C D, Rafaeloff-Phail R, Seng T, Suter T M, Sluka J P, et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 2000; 1: 81–88
   PubMedGoogle Scholar
• Yang W S, Lee W J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C L, Chen C L, Tai T Y, Chuang L M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815–3819
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599
   PubMed Web of Science ®Google Scholar
• Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 2094–2099
   PubMed Web of Science ®Google Scholar
• Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004; 191: 2120–2124
   PubMed Web of Science ®Google Scholar
• Thyfault J P, Hedberg E M, Anchan R M, Thorne O P, Isler C M, Newton E R, Dohm G L, deVente J E. Gestational diabetes is associated with depressed adiponectin levels. J Soc Gynecol Investig 2005; 12: 41–45
   PubMedGoogle Scholar
• Tsai P J, Yu C H, Hsu S P, Lee Y H, Huang I T, Ho S C, Chu C H. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005; 21: 1095–1099
   PubMed Web of Science ®Google Scholar
• Williams M A, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy D A. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 2306–2311
   PubMed Web of Science ®Google Scholar
• Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Coustan D R, Widness J A, Carpenter M W, Rotondo L, Pratt D C, Oh W. Should the fifty-gram, one-hour plasma glucose screening test for gestational diabetes be administered in the fasting or fed state. Am J Obstet Gynecol 1986; 154: 1031–1035
   PubMedGoogle Scholar
• Carpenter M W, Coustan D R. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768–773
   PubMed Web of Science ®Google Scholar
• Chen J, Tan B, Karteris E, Zervou S, Digby J, Hillhouse E W, Vatish M, Randeva H S. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006; 49: 1292–1302
   PubMed Web of Science ®Google Scholar
• Meller M, Qiu C, Vadachkoria S, Abetew D F, Luthy D A, Williams M A. Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus. Physiol Res 2006; 55: 501–512
   Google Scholar
• Cseh K, Baranyi E, Melczer Z, Kaszas E, Palik E, Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 2004; 27: 274–275
   PubMed Web of Science ®Google Scholar
• Lindsay R S, Walker J D, Havel P J, Hamilton B A, Calder A A, Johnstone F D. Adiponectin is present in cord blood but is unrelated to birth weight. Diabetes Care 2003; 26: 2244–2249
   PubMed Web of Science ®Google Scholar
• Chan T F, Yuan S S, Chen H S, Guu C F, Wu L C, Yeh Y T, Chung Y F, Jong S B, Su J H. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstet Gynecol Scand 2004; 83: 165–169
   PubMed Web of Science ®Google Scholar
• Catalano P M, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, Hauguel-De Mouzon S. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006; 49: 1677–1685
   PubMed Web of Science ®Google Scholar
• Cohen O, Epstein G S, Weisz B, Homko C J, Sivan E. Longitudinal assessment of insulin sensitivity in pregnancy. Validation of the homeostasis model assessment. Clin Endocrinol (Oxf) 2006; 64: 640–644
   PubMedGoogle Scholar
• Kirwan J P, Huston-Presley L, Kalhan S C, Catalano P M. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001; 24: 1602–1607
   PubMed Web of Science ®Google Scholar
• Parretti E, Lapolla A, Dalfra M, Pacini G, Mari A, Cioni R, Marzari C, Scarselli G, Mello G. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 2006; 47: 449–453
   PubMed Web of Science ®Google Scholar
• D'Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, Di Benedetto A. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 2006; 113: 1264–1269
   PubMed Web of Science ®Google Scholar
• Silha J V, Nyomba B L, Leslie W D, Murphy L J. Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care 2007; 30: 286–291
   Google Scholar
• Owecki M, Miczke A, Pupek-Musialik D, Bryl W, Cymerys M, Nikisch E, Sowiński J. Circulating serum adiponectin concentrations do not differ between obese and non-obese caucasians and are unrelated to insulin sensitivity. Horm Metab Res 2007; 39: 25–30
   Google Scholar
• Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52: 1274–1278
   PubMed Web of Science ®Google Scholar
• Altinova A E, Toruner F, Bukan N, Yasar D G, Akturk M, Cakir N, Arslan M. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J 2007; 54: 221–226
   Google Scholar